secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acrivon Therapeutics, Inc. (ACRV)
CIK:        0001781174
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001193125-23-060173
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Acrivon Therapeutics sets 2023 annual meeting for June 22, 2023
---------------------------------------------------------------

- First annual meeting of stockholders scheduled for June 22, 2023.
- Rule 14a-8 stockholder proposals must be received by March 13, 2023.
- Advance notice for director nominations and other proposals due by March 17, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781174/000119312523060173/0001193125-23-060173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781174/000119312523060173/d444684d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-060173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer